| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023026369 |
| P356 | DOI | 10.1007/S12265-012-9404-5 |
| P932 | PMC publication ID | 3518575 |
| P698 | PubMed publication ID | 23015462 |
| P2093 | author name string | Burns C Blaxall | |
| Melissa L Martin | |||
| P2860 | cites work | Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). | Q44103977 |
| Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes | Q44145604 | ||
| Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism | Q44346320 | ||
| Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study | Q44433022 | ||
| Expression of beta2-adrenergic receptor and its effect on the proliferation of neonatal rat cardiac fibroblasts | Q44484681 | ||
| Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats | Q44629578 | ||
| Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study | Q44799903 | ||
| Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin | Q45146701 | ||
| Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. | Q45270718 | ||
| Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. | Q45859164 | ||
| Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction | Q45869119 | ||
| New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice | Q45876621 | ||
| Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure | Q45883186 | ||
| Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts | Q46061333 | ||
| IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis | Q46139327 | ||
| Cellular basis for the acute inhibitory effects of IL-6 and TNF- alpha on excitation-contraction coupling | Q46452029 | ||
| MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species | Q46759097 | ||
| Atherosclerosis in mice is not affected by a reduction in tissue factor expression | Q46817967 | ||
| Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure | Q46852734 | ||
| Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. | Q46919151 | ||
| Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. | Q46930518 | ||
| Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. | Q46934593 | ||
| Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras. | Q46976750 | ||
| MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway | Q47745112 | ||
| Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling | Q47785069 | ||
| Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
| Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). | Q47945239 | ||
| B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation | Q48092800 | ||
| Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression | Q48350568 | ||
| Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 | ||
| Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy | Q24316322 | ||
| Interleukin-17 family and IL-17 receptors | Q28185677 | ||
| Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure | Q28213432 | ||
| IL-17: prototype member of an emerging cytokine family | Q28214946 | ||
| beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling | Q28378125 | ||
| Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats | Q28565373 | ||
| Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors | Q28573949 | ||
| Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 | Q28637521 | ||
| TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
| Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
| Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
| Cardiac fibroblast: the renaissance cell | Q30467800 | ||
| Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia | Q30482281 | ||
| Intramyocardial fibroblast myocyte communication | Q33586605 | ||
| Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy | Q33765289 | ||
| beta-adrenergic receptor blockade in chronic heart failure | Q33831388 | ||
| Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice | Q33854391 | ||
| TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression | Q33936542 | ||
| Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy | Q33963098 | ||
| Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure | Q34077136 | ||
| Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. | Q34198891 | ||
| Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. | Q34222208 | ||
| Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice | Q34270015 | ||
| Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness | Q34301819 | ||
| Inflammatory cytokines and postmyocardial infarction remodeling | Q34329136 | ||
| TGF-beta signaling in cancer--a double-edged sword | Q34421804 | ||
| NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts | Q34453246 | ||
| Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts | Q34588914 | ||
| Cardiac plasticity | Q34764732 | ||
| CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. | Q34784540 | ||
| The origin of fibroblasts and mechanism of cardiac fibrosis | Q34994036 | ||
| Ventricular remodeling in a mouse model of myocardial infarction | Q74612209 | ||
| Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials | Q77319724 | ||
| Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion | Q77905060 | ||
| Adrenergic stimulation and blocking of hormonal secretion activity of cultured cow granulosa cells | Q79623056 | ||
| The influence of alpha-adrenergic receptors stimulator and blockers and beta-blocker on the ovary and endocrinological activity in heifers during superovulation | Q79623067 | ||
| A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability | Q79717755 | ||
| Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy | Q79731289 | ||
| Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction | Q80117035 | ||
| Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction | Q80312750 | ||
| Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury | Q80312880 | ||
| Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation | Q80609219 | ||
| Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction | Q80987635 | ||
| Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling | Q81302999 | ||
| Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts | Q81573745 | ||
| Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo | Q84405590 | ||
| Cardiovascular Therapeutic Discovery | Q84961706 | ||
| IL-17A levels increase in the infarcted region of the left ventricle in a rat model of myocardial infarction | Q85266747 | ||
| Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications | Q37536067 | ||
| SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts | Q37617543 | ||
| TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 | ||
| TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients | Q38288920 | ||
| IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation | Q38297511 | ||
| TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. | Q39737677 | ||
| PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 | ||
| Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop | Q40875349 | ||
| Basic mechanisms in heart failure: the cytokine hypothesis | Q41188647 | ||
| Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice | Q41871986 | ||
| The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha | Q41884253 | ||
| Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). | Q41888678 | ||
| Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. | Q41892979 | ||
| Interstitial remodeling in beta1-adrenergic receptor transgenic mice | Q41918298 | ||
| Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy | Q42097897 | ||
| Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis | Q42170189 | ||
| Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site | Q42177034 | ||
| β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells. | Q42219763 | ||
| Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes | Q42444910 | ||
| ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts | Q42511347 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells | Q42979847 | ||
| Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation | Q43065625 | ||
| Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner | Q43223343 | ||
| Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes | Q43281057 | ||
| Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling | Q43514127 | ||
| beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase | Q43667899 | ||
| Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts. | Q43745368 | ||
| Effect of losartan on circulating TNFalpha levels and left ventricular systolic performance in patients with heart failure. | Q43794796 | ||
| Sphingosine modulates myocyte electrophysiology, induces negative inotropy, and decreases survival after myocardial ischemia | Q43822564 | ||
| Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat. | Q43822584 | ||
| Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases | Q44016918 | ||
| Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene | Q44088296 | ||
| Inflammatory mediators and the failing heart: past, present, and the foreseeable future | Q35011415 | ||
| Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease | Q35057480 | ||
| Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction | Q35103051 | ||
| CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis | Q35159918 | ||
| Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. | Q35685792 | ||
| Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases | Q35748162 | ||
| Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis | Q35760651 | ||
| Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility | Q35786123 | ||
| Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation | Q35829716 | ||
| TGF-beta1 and angiotensin networking in cardiac remodeling | Q35846911 | ||
| The dynamics of fibroblast-myocyte-capillary interactions in the heart | Q35869237 | ||
| Duality of innate stress responses in cardiac injury, repair, and remodeling | Q35893782 | ||
| Cytokine-induced modulation of cardiac function | Q35980361 | ||
| Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone | Q35989215 | ||
| TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. | Q36001319 | ||
| Chemokines in the ischemic myocardium: from inflammation to fibrosis | Q36031330 | ||
| Role of transforming growth factor Beta in human cancer | Q36073421 | ||
| The cardiac fibroblast: therapeutic target in myocardial remodeling and failure | Q36094597 | ||
| Matrix metalloprotease-1a promotes tumorigenesis and metastasis | Q36097959 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| The role of TGF-beta signaling in myocardial infarction and cardiac remodeling | Q36655326 | ||
| Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. | Q36734858 | ||
| Survival pathways in hypertrophy and heart failure: the gp130-STAT axis | Q36961847 | ||
| Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function | Q36967674 | ||
| Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis | Q37061090 | ||
| Transforming growth factor-beta (TGF-beta) and brain tumours. | Q37190193 | ||
| Pharmacologic therapies across the continuum of left ventricular dysfunction | Q37250177 | ||
| Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes | Q37302419 | ||
| Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits | Q37357497 | ||
| Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death | Q37362206 | ||
| IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. | Q37415365 | ||
| Cardiac fibroblasts: at the heart of myocardial remodeling | Q37491524 | ||
| Connective tissue growth factor and cardiac fibrosis after myocardial infarction. | Q50763650 | ||
| Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. | Q51026909 | ||
| Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. | Q51083125 | ||
| Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? | Q51789753 | ||
| Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. | Q52583103 | ||
| Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. | Q52853439 | ||
| Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. | Q52900479 | ||
| Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction | Q58047222 | ||
| Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure | Q59192155 | ||
| Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) | Q59192167 | ||
| IL-1β stimulates rat cardiac fibroblast migration via MAP kinase pathways | Q61847419 | ||
| β-Adrenergic Stimulation of Cardiac Non-myocytes Augments the Growth-promoting Activity of Non-myocyte Conditioned Medium | Q61847495 | ||
| MCP-1 Induces a Novel Transcription Factor With Proapoptotic Activity | Q63915221 | ||
| Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors | Q64966731 | ||
| Effect of growth factors on collagen metabolism in cultured human heart fibroblasts | Q68266203 | ||
| Elevated circulating levels of tumor necrosis factor in severe chronic heart failure | Q68524243 | ||
| Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs | Q71006312 | ||
| Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart | Q71102878 | ||
| Induction of hypertrophic responsiveness to isoproterenol by TGF-beta in adult rat cardiomyocytes | Q71569122 | ||
| Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists | Q71705747 | ||
| Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro | Q72198705 | ||
| Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1 | Q72790353 | ||
| Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy | Q73013948 | ||
| Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion | Q73047639 | ||
| Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes | Q73120309 | ||
| Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure | Q73250285 | ||
| Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure | Q73252346 | ||
| Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts | Q73256082 | ||
| Plasma cytokine parameters and mortality in patients with chronic heart failure | Q73306471 | ||
| Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha | Q73310597 | ||
| Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium | Q73554713 | ||
| Chemokines and CD40 expression in human fibroblasts | Q73603880 | ||
| Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat | Q73693685 | ||
| Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha | Q73742574 | ||
| Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression | Q73815462 | ||
| Coupling function of endogenous alpha(1)- and beta-adrenergic receptors in mouse cardiomyocytes | Q73825677 | ||
| Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors | Q73825680 | ||
| Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes | Q73870564 | ||
| Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro | Q73919594 | ||
| Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats | Q74162665 | ||
| IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury | Q74183226 | ||
| Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction | Q74327745 | ||
| Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor | Q74364510 | ||
| Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats | Q74397793 | ||
| Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats | Q74477478 | ||
| Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats | Q74522770 | ||
| Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | Q74595368 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 768-782 | |
| P577 | publication date | 2012-09-27 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? | |
| P478 | volume | 5 |
| Q42256221 | Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts |
| Q85969580 | Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? |
| Q34675044 | Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway |
| Q92860231 | Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling |
| Q88711547 | Cellular Communications in the Heart |
| Q36699619 | Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression |
| Q38204265 | Crosstalk between fibroblasts and inflammatory cells |
| Q37359133 | Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease |
| Q64235554 | Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts |
| Q38632188 | Extracellular matrix-mediated cellular communication in the heart. |
| Q50197350 | Fatty Infiltration of the Myocardium and Arrhythmogenesis: Potential Cellular and Molecular Mechanisms |
| Q37725769 | Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue? |
| Q38780801 | From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure |
| Q37145880 | Generating primary cultures of murine cardiac myocytes and cardiac fibroblasts to study viral myocarditis |
| Q38626688 | Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). |
| Q38175768 | Influence of mechanical stress on fibroblast-myocyte interactions in mammalian heart |
| Q38653648 | Mechanical control of cardiac myofibroblasts |
| Q35151951 | Mechanotransduction mechanisms for intraventricular diastolic vortex forces and myocardial deformations: part 1. |
| Q92731261 | MicroRNA-21 Mediates the Protective Effect of Cardiomyocyte-Derived Conditioned Medium on Ameliorating Myocardial Infarction in Rats |
| Q64081784 | Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure |
| Q64081805 | Putting the Heat on Cardiac Fibrosis: Hsp20 Regulates Myocyte-To-Fibroblast Crosstalk |
| Q38190443 | Regulatory RNAs and paracrine networks in the heart. |
| Q93387384 | Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts |
| Q91289538 | The interstitium in cardiac repair: role of the immune-stromal cell interplay |
| Q49917356 | Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts |
| Q50849341 | cIAP-2 protects cardiac fibroblasts from oxidative damage: an obligate regulatory role for ERK1/2 MAPK and NF-κB. |
Search more.